Building a Moat with Red Tape
We often talk about a company’s “moat,” its defence against competitors. We think of strong brands or efficient supply chains. A regulatory moat, however, can be the most effective of all. It’s a barrier built from paperwork, clauses, and standards that you helped put in place. It’s devilishly difficult for a new competitor to navigate a maze that was designed by the incumbent.
This is particularly true in sectors like pharmaceuticals and finance. The process of getting a new drug approved or complying with banking capital requirements is immensely complex and expensive. For companies with established political connections, it’s a familiar landscape. For newcomers, it can be a death trap. This influence might not show up on a balance sheet, but its effects on long term profitability could be profound. A collection of companies that have mastered this, such as those in the Friends in High Places basket, demonstrates how this strategy plays out across different sectors.
Of course, this strategy is not without its perils. Political winds can and do change. A friendly administration can be replaced by a hostile one, turning a valuable asset into a liability overnight. Public opinion can also turn against companies seen as too cosy with government, creating significant reputational risk. Investing in political influence is not a guaranteed path to success, it’s a high stakes game that requires constant attention. But in a world governed by rules, it’s naive to ignore the players who have a hand in writing them.